AC Immune SA Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by AC Immune SA, a foreign private issuer headquartered in Lausanne, Switzerland, for the month of October 2020. The filing date is October 21, 2020. The document serves to notify the SEC of the convening of an Extraordinary Shareholders' Meeting.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a procedural filing regarding corporate governance and does not contain financial statements or performance data.
Material Changes
No material changes to financial performance or operations are reported in this document. The filing focuses solely on the administrative process of holding a shareholder meeting.
Guidance, Outlook, and Risks
The filing includes no management commentary, financial guidance, or discussion of risks and contingencies. The primary content consists of an invitation to the Extraordinary Shareholders' Meeting and a proxy card (Exhibits 99.1 and 99.2).
Key Facts for Investors
- The company is convening an Extraordinary Shareholders' Meeting.
- Exhibits 99.1 and 99.2 contain the meeting invitation and proxy card, respectively.
- This filing contains no financial data or operational updates for the period.
- The report was signed by CEO Andrea Pfeifer and CFO Joerg Hornstein.